Screener
United Therapeutics UTHR Market capitalization
Market capitalization at other companies
Other financials
Where this comes from
Computed from the period-end share price: $25.99B.
The source filing: United Therapeutics’s 10-Q, filed May 6, 2026. Open the filing →
- Filed
- May 6, 2026, 6:30 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001082554-26-000020
FAQ
- What is United Therapeutics's market capitalization?
- United Therapeutics (UTHR) reported market capitalization of $25.99B in Q1 2026.
- How has United Therapeutics's market capitalization changed year-over-year?
- United Therapeutics's market capitalization increased by 87.7% year-over-year, from $13.85B to $25.99B.
- What is the long-term trend for United Therapeutics's market capitalization?
- Over 5 years (2020 to 2025), United Therapeutics's market capitalization has grown at a 25.1% compound annual growth rate (CAGR), from $6.84B to $20.98B.
- What does market capitalization mean?
- The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.
Ask your AI about United Therapeutics's market capitalization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude